ERBB-2 gene overexpression and amplification in uterine sarcomas

ERBB-2 gene overexpression and amplification in uterine sarcomas
复制标题

DOI:
10.1016/j.ygyno.2004.07.041
复制
发表时间:
2004-12-01
影响因子:
4.7
通讯作者:
Vergote, I
Vergote, I
中科院分区:
医学2区
文献类型:
--
作者:
Amant, F;Vloeberghs, V;Vergote, I

文献摘要

被引文献

相似文献

背景。本研究的目的是确定不同亚型子宫肉瘤中 ERBB-2 (HER-2/neu) 基因的改变。集中审查后,对代表性活检进行免疫组织化学染色,并半定量评分为阴性、弱(1+)、中度(2+)或强(3+)阳性。随后,对2+和3+表达的病例进行荧光原位杂交(FISH)。结果。评估了 70 个肿瘤(52 个原发肿瘤和 18 个复发肿瘤)。所有 10 例腺肉瘤、21 例子宫内膜间质肉瘤和 10 例平滑肌肉瘤在原发和复发情况下均为阴性。对二十二个原发性癌肉瘤进行了评分。上皮成分呈阴性/1+ 16 例(73%),2+/3+ 5 例(22.5%),无法评估 1 例(4.5%),而肉瘤成分染色阴性/1+ 21 例(95.5%),3+(4.5%)1 例。在两个复发性癌肉瘤中,上皮成分染色均为 3+,而肉瘤成分染色为阴性和 1+。通过 FISH 测定,在具有 2+ 或 3+ 过表达的癌肉瘤中观察到 ERBB-2 基因扩增,导致总体扩增率为 3/22 (14%)。四分之一的未分化子宫肉瘤染色为 2+。复发肿瘤中证实了ERBB-2免疫阳性(3+)和FISH检测的ERBB-2扩增,导致未分化子宫肉瘤的基因扩增率为1/4。结论。目前的结果表明,ERBB-2在子宫平滑肌肉瘤、子宫腺肉瘤和子宫内膜间质肉瘤中不存在过表达,而ERBB-2基因可能在子宫癌肉瘤和未分化子宫肉瘤中具有生物学作用。 (C) 2004 Elsevier Inc. 保留所有权利。
Background. The aim of this study was to determine ERBB-2 (HER-2/neu) gene alterations in different subtypes of uterine sarcomas.Methods. After central review, representative biopsies were immunohistochemically stained and semiquantitatively scored as negative, weakly (1+), moderately (2+), or strongly (3+) positive. Subsequently, fluorescence in situ hybridization (FISH) was performed on cases with 2+ and 3+ expression.Results. Seventy tumors (52 primaries and 18 recurrent) were evaluated. All 10 adenosarcomas, 21 endometrial stromal sarcomas, and 10 leiomyosarcomas were negative both in the primary and recurrent setting. Twenty-two primary carcinosarcomas were scored. The epithelial component was negative/1+ in 16 (73%), 2+/3+ in five (22.5%) tumors, and could not be evaluated in one case (4.5%), whereas the sarcoma component stained negative/1+ in 21 cases (95.5%) and 3+ (4.5%) in one case. In two recurrent carcinosarcomas, the epithelial component stained 3+ in both cases, whereas the sarcoma component scored negative and 1+. Amplification of the ERBB-2 gene as determined by FISH was observed in 3/7 (43%) carcinosarcomas with 2+ or 3+ overexpression, resulting in an overall 3/22 (14%) amplification rate. One out of four undifferentiated uterine sarcomas stained 2+. ERBB-2 immunopositivity (3+) and ERBB-2 amplification by FISH were confirmed in the recurrent tumor, resulting in a gene amplification rate of 1/4 in undifferentiated uterine sarcomas.Conclusion. The current results suggest absence of ERBB-2 overexpression in uterine leiomyosarcoma, uterine adenosarcoma, and endometrial stromal sarcoma, whereas the ERBB-2 gene might have a biologic role in uterine carcinosarcoma and undifferentiated uterine sarcomas. (C) 2004 Elsevier Inc. All rights reserved.